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Himachal Pradesh state of India is situated in the outer
Himalayan ranges. During the rainy season, several cases
of acute febrile illness of unknown origin occurred. Orientia
tsutsugamushi was identified as the causative agent by
microimmunofluorescence and PCR. Two new genotypes of
O. tsutsugamushi were identified in the region.
M
icroimmunofluorescence (MIF) assay is the test of
choice to diagnose rickettsial diseases (1,2), but
more sensitive serologic tests and real-time quantitative
PCR are expected to increase the number of cases diag-
nosed (3). Rickettsial diseases have been reported from
various regions of India in the recent past (4–6); in the past
few years, acute febrile illness with multiple organ involve-
ment was diagnosed in several patients in our area. Results
of tests for common causes of fever were negative, as were
results of serologic tests for infectious mononucleosis,
immunoglobulin M (IgM) for dengue fever, and IgM for
leptospirosis. Sixteen of 31 serum samples from patients
with suspected scrub typhus had titers 40–160 on Weil-
Felix agglutination test with Proteus OXK antigen in 2003.
Himachal Pradesh is a mountainous state in northern
India, situated in the outer Himalayas, with altitudes
350–7,000 m above sea level. It is the least urbanized state
in India. During the rainy season, areas at lower altitudes
have an average temperature of 20°C to 35°C, which is
conducive to the spread of arthropod vectors. We recently
reported an outbreak of scrub typhus in these areas (7). In
an entomologic study in Himachal Pradesh, vector species
Leptotrombidium deliense and Gahrliepia (schoengastilla)
spp. were recorded (8). The aim of the present study was
to retrospectively diagnose suspected rickettsial disease
(scrub typhus) by using MIF assay and molecular methods
in patients with acute febrile illness of unknown origin.
The Study
The study was conducted from July through October
2004. Scrub typhus was suspected by clinical manifesta-
tions such as febrile illness or fever with rash or eschar.
After giving informed consent, patients filled out question-
naires about potential chigger exposure and symptoms or
signs consistent with scrub typhus. Blood samples were
taken from all patients for total blood cell count, biochem-
ical analysis, serologic diagnosis, and molecular assays.
This study was exempt from human subject review.
When they sought treatment, 5 patients had been symp-
tomatic for 5 to 7 days, 14 had been symptomatic for 8 to
14 days, and the remaining 2 had been symptomatic for 18
to 25 days. Blood samples were collected at the time of
admission to the hospital, and no serial assays were per-
formed. All patients with clinical features that suggested
scrub typhus received antirickettsial drugs (doxycycline/
azithromycin) empirically.
Two serologic tests were used to confirm infections.
The Weil-Felix Proteus agglutination assay with Proteus
vulgaris OX-19 and OX-2 and P. mirabilis OX-K strains
(Wellcome Diagnostics, Dartford, UK) was performed on
each sample; a titer >80 was considered positive. Serum
specimens were stored at –20°C. Serum specimens were
tested by MIF assay with a panel of 11 rickettsial antigens,
including spotted fever group (SFG) rickettsiae (Rickettsia
japonica, R. helvetica, R. slovaca, R. conorii subsp. indi-
ca, R. honeï, R. heilongjangensis, and R. felis), R. typhi,
and  Orientia tsutsugamushi (Gilliam, Karp, Kato and
Kawasaki strains) (3). The MIF assay was considered pos-
itive if antibody titers were >128 for IgG and >64 for IgM
or if seroconversion was demonstrated (9,10).
DNA was extracted from the blood sample (buffy coat)
by using QIAamp DNA Mini Kit (Qiagen GmbH, Hilden,
Germany) according to the manufacturer’s instructions.
Two amplification reactions were performed: 1) a real-
time quantitative PCR with a TaqMan probe targeting the
47-kDa outer membrane protein with primers and probe
previously described (11) and 2) a standard PCR targeting
the 56-kDa protein with forward and reverse primers
(OtsuF: 5′-AATTGCTAGTGCAATGTCTG-3′ and OtsuR:
5′-GGCATTATAGTAGGCTGAG-3′). The primers were
purchased from Eurobio (Paris, France). The success of the
amplification was confirmed by resolution of the products
by electrophoresis on 1% agarose gel (Sigma Chemical
Co., Saint Louis, MO, USA) in 1×Tris borate EDTAbuffer
for products of the 56-kDa gene. The sizes of the PCR-
amplified products were determined by comparison with a
molecular weight standard (Boehringer, Manheim,
Germany) under UV light after ethidium bromide staining.
The PCR products were purified by using the QIAquick
PCR Purification Kit (Qiagen) according to the manufac-
turer’s instructions. Sequencing reactions were performed
with a DNAsequencing kit, dRhodamine Terminator Cycle
Sequencing Ready Reaction Mix (Applied Biosystems,
Foster City, CA, USA). Sequencing was performed on an
ABI PRISM 310 DNA Sequencer (Applied Biosystems).
The sequences were identified by comparison with
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In the MIF assay, samples from 21 patients showed pos-
itive antibody titers (both IgG and IgM) to O. tsutsuga-
mushi (Gilliam, Karp, Kato, and Kawasaki strains).
Twenty-eight of 51 serum samples had titers 80–320 to
Proteus OXK antigen on Weil-Felix test, of which only 13
had titers on MIF. Moreover, samples from 15 patients with
titers on Weil-Felix did not show titers on MIF, and samples
from 8 patients without titers on Weil-Felix showed titers
on MIF. None of the patients had a positive serologic test
result for SFG rickettsioses. Real-time quantitative PCR to
O. tsutsugamushi was positive in anticoagulated blood of 3
patients, and this result was confirmed by using primers for
the 56-kDa antigen gene of O. tsutsugamushi. Patient 1 had
a sequence (GenBank accession no. DQ530440) that
matched the Karp type, close to strain LA-1 isolated in
1993 in Malaysia from mites (12). The sequence obtained
from patient 2 (GenBank accession no. DQ530441)
matched the sequence between the JG type and a recently
described new subtype called Saitama, described in Japan
(13). The results of MIF assays are shown in Table 1. The
clinical features and laboratory abnormalities found in
these 21 patients are shown in Table 2.
By MIF assay, 11 of 21 samples had positive titers of
both IgG and IgM; 3 were positive for IgG (but not IgM)
and were positive on PCR. These 14 patients had acute
infection and are considered to have had scrub typhus,
whereas the remaining 7 patients with only IgG titers are
considered as probable scrub typhus case-patients. In cases
of primary infection with O. tsutsugamushi, IgM appears
at the end of the first week, whereas IgG appears at the end
of the second week. However, in the case of reinfection
with O. tsutsugamushi, IgG is detectable by day 6, and
IgM titers are variable. The absence of IgM in 10 samples
can be attributable to previous antigenic conditioning from
reinfection (9). Moreover all 3 patients with positive PCR
results had IgG titers but not IgM titers, which suggests
that some of the remaining 7 patients with only IgG might
also have been acutely infected.
Conclusions
We confirmed the diagnosis of scrub typhus in 21
patients from the Himalayas with several validated assays.
PCR was performed in a few cases to further confirm O.
tsutsugamushi, and we found that PCR was a good tool for
molecular diagnosis, as recently reported (6). To the best
of our knowledge, this is the first molecular detection of O.
tsutsugamushi in southern Asia. The result was confirmed
by using 2 different target genes in 2 different PCR assays.
In our study, >2 different genotypes were identified; the
phylogenetic position of 1 is between Karp and JP-1, and
the other is between Saitama and JG type (Figure).
Therefore, isolating these strains is recommended to
increase understanding of the epidemiologic features of
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Table 2. Distribution of clinical features in 21 patients with 
suspected scrub typhus, Himalayas, 2004  
Clinical feature*  
Men  
(n = 13) 
Women  
(n = 8)  Total (%) 
Fever  13  8  21 (100) 
Chills and rigor   10  5  15 (71.4) 
Vomiting  6  3  9 (42.8) 
Myalgia  4  4  8 (38.0) 
Headache  4  4  8 (38.0) 
Altered sensorium   2  3  5 (23.8) 
Lymphadenopathy   9  2  11 (52.3) 
Jaundice  5  6  11 (52.3) 
Hepatomegaly  6  3  9 (42.8) 
Congested eyes   5  2  7 (33.3) 
Splenomegaly  4  3  7 (33.3) 
Abdominal pain  2  4  6 (28.5) 
Seizures  2  2  4 (19.0) 
Cough  2  2  4 (19.0) 
Abnormal bleeding   1  2  3 (14.2) 
Eschar  2  0  2 (9.5) 
Meningeal signs   1  1  2 (9.5) 
Rash  2  0  2 (9.5) 
Elevated transaminase  levels  7  7  14 (66.7) 
Renal dysfunction   8  6  14 (66.7) 
Proteinuria  5  3  8 (38.1) 
CSF abnormalities†   1  2  3 (14.3) 
Acute RDS  1  1  2 (9.5) 
*CSF, cerebrospinal fluid; RDS, respiratory distress syndrome.  
†Elevated protein level and increased lymphocyte count.  scrub typhus in India (12). In our study, an eschar, which
is formed in few secondary infections (2), was noted in
9.5% of cases. Eschars are rare in Southeast Asian patients,
and indigenous persons of typhus-endemic areas common-
ly have less severe illness, often without rash or eschar
(14). The variation in cutaneous immunity has also been
suggested as a possible explanation for the absence of an
eschar in certain instances of scrub typhus (15).
The literature mentions this disease in hilly regions of
the Himalayas and the Shimla region in Himachal Pradesh
(5,7,15), but specific data are not available. The disease
must have been present in the area but was not noticed
because, in the past, most cases of fever were treated with
drugs like tetracycline and chloramphenicol, which effec-
tively treat scrub typhus also. The incidence of pyrexia of
unknown origin with multiple organ involvement has
increased for the past few years, which prompted us to
conduct this study. Increasing prevalence of scrub typhus
has been reported from some Asian countries, which coin-
cides with the widespread use of β-lactam antimicrobial
drugs and urbanization in rural areas (14).
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Figure. Phylogenetic tree produced by unweighted pair-group
method with arithmetic means that shows the positions of IHS I
and IHS II genotypes based on the partial 56-kDa sequence
homologies. Numbers at nodes indicate bootstrap values, and the
scale bar shows genetic distance of 0.02.